Evidence map›Paper›PMID 36831915›Full record

ArticleBiosensors2023

Silver Nanostar-Based SERS for the Discrimination of Clinically Relevant

Miguel Peixoto de Almeida, Carla Rodrigues, Ângela Novais, Filipa Grosso, Nicolae Leopold, Luísa Peixe, Ricardo Franco, Eulália Pereira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miguel Peixoto de AlmeidaLAQV/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal.ORCID 0000-0001-8621-4701
Carla RodriguesUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-9608-2404
Ângela NovaisUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-1171-0326
Filipa GrossoUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Nicolae LeopoldFaculty of Physics, Babeş-Bolyai University, 400084 Cluj-Napoca, Romania.
Luísa PeixeUCIBIO-Applied Molecular Biosciences Unit, Department of Biological Sciences, Laboratory of Microbiology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0001-5810-8215
Ricardo FrancoAssociate Laboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.ORCID 0000-0002-5139-2871
Eulália PereiraLAQV/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, 4169-007 Porto, Portugal.ORCID 0000-0003-2086-5696

Funding

Associate Laboratory for Green Chemistry UIDB/50006/2020 and UIDP/50006/2020Fundação para a Ciência e Tecnologia CEEC program (2021.02252.CEECIND/CP1662/CT0009) to ANFundação para a Ciência e Tecnologia LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HBFundação para a Ciência e Tecnologia Transitional norm (DL57/2016/CP1346/CT0034) to FGFundação para a Ciência e Tecnologia UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences - UCIBIORomanian Ministry of Research and Innovation, CCCDI-UEFISCDI PN-III-P4-ID-PCE-2020-1292, within PNCDI III
6 · The paper itself

Abstract

The development of rapid, reliable, and low-cost methods that enable discrimination among clinically relevant bacteria is crucial, with emphasis on those listed as WHO Global Priority 1 Critical Pathogens, such as carbapenem-resistant

Indexed as

Acinetobacter baumanniiBacteriaCarbapenemsClone CellsKlebsiella pneumoniaePilot ProjectsSilverSpectrum Analysis, RamanCarbapenemsSilverbacterial differentiationchemometricsclonescritical pathogensSERSsilver nanostarssurface-enhanced Raman spectroscopyvibrational spectroscopy

Identifiers

PMID36831915
PMCPMC9953856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.